Published in Ugeskr Laeger on July 11, 1988
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Shifts in selective visual attention: towards the underlying neural circuitry. Hum Neurobiol (1985) 4.78
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66
Toward understanding insulin fibrillation. J Pharm Sci (1997) 2.24
The interpretation of structure from motion. Proc R Soc Lond B Biol Sci (1979) 2.23
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma) Br J Rheumatol (1998) 1.91
Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis (2004) 1.90
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
Visual routines. Cognition (1984) 1.76
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
[Chronic fatigue syndrome--a defined unity?]. Ugeskr Laeger (1994) 1.71
Definition of the phenotype. Adv Genet (2001) 1.68
High prevalence of coeliac disease in Danish children with type I diabetes mellitus. Acta Paediatr (2001) 1.65
Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int (2000) 1.64
Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunology (1993) 1.64
Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol (1993) 1.64
Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy (1980) 1.59
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
A prospective study of medically treated acute type B aortic dissection. Eur J Vasc Endovasc Surg (2006) 1.56
Aligning pictorial descriptions: an approach to object recognition. Cognition (1989) 1.55
Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit. J Clin Epidemiol (1992) 1.54
Bilateral angle-closure glaucoma in association with the acquired immune deficiency syndrome. Am J Ophthalmol (1986) 1.54
Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis (2007) 1.51
Factors affecting survival in juvenile systemic sclerosis. Rheumatology (Oxford) (2008) 1.49
Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes (1994) 1.48
Treatment of chlamydial urethritis in men and Chlamydia trachomatis-positive female partners: comparison of erythromycin and tetracycline in treatment courses of one week. Sex Transm Dis (1983) 1.45
Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol (1995) 1.45
[Intra-articular glucocorticoid injections in joint diseases]. Ugeskr Laeger (1999) 1.44
Scintimetric assessment of synovitis activity during treatment with disease modifying antirheumatic drugs. Ann Rheum Dis (1988) 1.41
Directional selectivity and its use in early visual processing. Proc R Soc Lond B Biol Sci (1981) 1.41
Trimethoprim-sulphamethoxazole in gonorrhoea. Acta Derm Venereol (1971) 1.39
Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos. Eur Respir J (1997) 1.37
Organ specific antibodies in Addison's disease. Acta Med Scand Suppl (1966) 1.32
Vasculitis in granuloma annulare: histopathology and direct immunofluorescence. Arch Dermatol (1977) 1.28
Spatial context in recognition. Perception (1996) 1.25
The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens. Clin Exp Immunol (1995) 1.25
Cellular hypersensitivity in Hashimoto's thyroiditis. Specific action of thyroid extract upon the migration of leucocytes in vitro. Acta Med Scand (1968) 1.23
Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J (Clin Res Ed) (1987) 1.22
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol (1999) 1.15
Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis. Scand J Respir Dis (1975) 1.13
Quantitative determination of immunoglobulins in nasal secretion. Int Arch Allergy Appl Immunol (1975) 1.12
Immunological studies in two children with recurrent parotitis. Acta Paediatr Scand (1983) 1.10
Antinuclear factors in sera from healthy blood donors. Acta Pathol Microbiol Scand C (1976) 1.09
Organ antibodies in Sjögren's syndrome. Acta Allergol (1965) 1.09
Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods (1996) 1.08
[Chronic fatigue syndrome--a controlled cross-sectional study]. Ugeskr Laeger (1994) 1.08
Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis (1974) 1.06
Anti-neutrophil cytoplasm antibodies 1988. Lancet (1988) 1.06
Organ antibodies in disseminated lupus erythematosus. Acta Med Scand (1965) 1.06
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis (2011) 1.05
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol (1998) 1.05
Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea (1997) 1.05
High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol (1994) 1.04
Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol (1998) 1.04
The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) (2003) 1.04
Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int (1998) 1.03
Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice? Clin Exp Immunol (1995) 1.03
Clinical synovitis and radiological lesions in rheumatoid arthritis. A prospective study of 25 patients during treatment with remission-inducing drugs. Scand J Rheumatol (1983) 1.03
Enzyme-linked immunosorbent assay for determination of IgM rheumatoid factor. Scand J Rheumatol (1979) 1.03
A clinical study of 32 patients with oral discoid lupus erythematosus. Int J Oral Surg (1978) 1.02
Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol (1999) 1.02
Effect of genetic cross on the detection of quantitative trait loci and a novel approach to mapping QTLs. Pharmacol Biochem Behav (2000) 1.02
Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol (2004) 1.02
High-affinity binding sites for prostaglandin E on human lymphocytes. Cell Immunol (1979) 1.01
A supplemental labeling system for topical medications. Am J Ophthalmol (1987) 1.01
Humoral and cellular immunity in sarcoidosis. Acta Med Scand (1978) 1.01
Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant (1997) 1.00
Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease. Infect Immun (1988) 0.99
Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol (2001) 0.99
Granulocyte specific antinuclear antibodies in ulcerative colitis. Aid in differential diagnosis of inflammatory bowel disease. Acta Pathol Microbiol Immunol Scand C (1983) 0.99
Demonstration of electrophoretic heterogeneity of serum beta 2-microglobulin in systemic lupus erythematosus and rheumatoid arthritis: evidence against autoantibodies to beta 2-microglobulin. Scand J Immunol (1979) 0.98
Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988. APMIS Suppl (1989) 0.98
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study. Br J Rheumatol (1998) 0.98
Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. J Autoimmun (1999) 0.97
[A new MR-(and CT-) compatible bone biopsy system: first clinical results]. Rofo (1998) 0.97
Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. J Immunol Methods (1994) 0.97
Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors. Immunology (1972) 0.97
IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes. Ann Rheum Dis (1984) 0.97
Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. APMIS (1996) 0.96
Parallel and serial processes in motion detection. Science (1987) 0.96
Immunological studies in sarcoidosis: a comparison of disease activity and various immunological parameters. Ann N Y Acad Sci (1976) 0.96
[Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA)]. Ugeskr Laeger (1986) 0.95
Tetracycline versus silver nitrate pleurodesis in spontaneous pneumothorax. J Thorac Cardiovasc Surg (1983) 0.95
Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies. Acta Derm Venereol (1974) 0.95